Inventor
CHIANG JIA LI
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
A61KPreparations for medical, dental or toiletry purposes14%
C07DHeterocyclic compounds14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
PatentTitleYear
12,344,840Compositions of asymmetric interfering RNA and uses thereof202511,759,509WT1 antigen peptide conjugate vaccine202311,414,394Process for producing a hydrate of a hydrochloride salt of 2,2'-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to SUMITOMO PHARMA CO LTD (2)· patent assignee history
2022Patents assigned to SUMITOMO PHARMA ONCOLOGY INC (1)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to INT INST CANCER IMMUNOLOGY INC (1)· patent assignee history
2025Patents assigned to 1GLOBE HEALTH INST LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SUMITOMO PHARMA CO LTD | 2 | 2022–2023 |
| 1GLOBE HEALTH INST LLC | 1 | 2025 |
| INT INST CANCER IMMUNOLOGY INC | 1 | 2023 |
| SUMITOMO PHARMA ONCOLOGY INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2025 |